{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:25:01Z","timestamp":1793496301928,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011665","name":"King Saud University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["MED-P-S-02-2025-09"],"award-info":[{"award-number":["MED-P-S-02-2025-09"]}],"id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108565","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:54:22Z","timestamp":1746586462000},"page":"108565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Development of Benzothiazole-grafted Pyrazolo[1,5-a]pyrimidines as new CDK2 inhibitors and anti-prostate cancer agents"],"prefix":"10.1016","volume":"161","author":[{"given":"Mahmoud S.","family":"Elkotamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"Elgohary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Abdelrahman","family":"Alkabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Almehizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Naglah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem A.","family":"Ghabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9916","key":"10.1016\/j.bioorg.2025.108565_bb0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(13)62224-2","article-title":"Global cancer patterns: causes and prevention","volume":"383","author":"Vineis","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108565_bb0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2017.31","article-title":"The high price of anticancer drugs: origins, implications, barriers, solutions","volume":"14","author":"Prasad","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108565_bb0015","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/pros.24360","article-title":"Current and projected number of years of life lost due to prostate cancer: a global study","volume":"82","author":"Withrow","year":"2022","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108565_bb0020","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/cncr.26392","article-title":"Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality","volume":"118","author":"Scosyrev","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108565_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.ju.0000149989.01263.dc","article-title":"Cell lines used in prostate cancer research: a compendium of old and new lines\u2014part 2","volume":"173","author":"Sobel","year":"2005","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108565_bb0030","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.urology.2009.03.003","article-title":"Current prostate cancer treatments: effect on quality of life","volume":"73","author":"Gomella","year":"2009","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0035","doi-asserted-by":"crossref","first-page":"2250575","DOI":"10.1080\/14756366.2023.2250575","article-title":"Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi-and extensively drug resistant mycobacterium tuberculosis","volume":"38","author":"Hemeda","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108565_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112762","article-title":"2-substituted benzothiazoles as antiproliferative agents: novel insights on structure-activity relationships","volume":"207","author":"Ammazzalorso","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0045","doi-asserted-by":"crossref","first-page":"2166036","DOI":"10.1080\/14756366.2023.2166036","article-title":"New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study","volume":"38","author":"Al-Sanea","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0050","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1080\/14756366.2022.2124409","article-title":"Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII","volume":"37","author":"Al-Warhi","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108565_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111609","article-title":"Pyrazolo-benzothiazole hybrids: synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model","volume":"182","author":"Reddy","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108565_bb0060","doi-asserted-by":"crossref","first-page":"e1143","DOI":"10.1038\/cddis.2014.107","article-title":"SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI\/JNK-1 signaling pathway","volume":"5","author":"Peng","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.108565_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112618","article-title":"Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the hippo signaling pathway","volume":"203","author":"Song","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108565_bb0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3998\/ark.5550190.0009.f20","article-title":"Synthesis and in vitro antiproliferative activity of new benzothiazole derivatives","volume":"2008","author":"Al Soud","year":"2008","journal-title":"Arkivoc"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108565_bb0075","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/acschembio.1c00390","article-title":"Development of a benzothiazole scaffold-based androgen receptor N-terminal inhibitor for treating androgen-responsive prostate cancer","volume":"16","author":"Kuznik","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108565_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb4184","article-title":"Cyclin-dependent kinases","volume":"15","author":"Malumbres","year":"2014","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108565_bb0085","first-page":"1589","article-title":"Discovering new CDK2 inhibitors by molecular docking and drug-likeness-based virtual screening for potential anticancer uses","volume":"3","author":"Elkotamy","year":"2024","journal-title":"ERU Research Journal"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108565_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.70009","article-title":"Molecular docking, DFT and antiproliferative properties of 4-(3, 4-dimethoxyphenyl)\u2212 3-(4-methoxyphenyl)\u2212 1-phenyl-1H-pyrazolo [3, 4-b] pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency","volume":"85","author":"Binjubair","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108565_bb0095","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/ddr.22079","article-title":"Design, synthesis, and biological evaluation of furan-bearing pyrazolo [3, 4-b] pyridines as novel inhibitors of CDK2 and P53\u2013MDM2 protein\u2013protein interaction","volume":"84","author":"Ezzat","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0100","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/14756366.2022.2062337","article-title":"Identification of 3-(piperazinylmethyl) benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights","volume":"37","author":"Eldehna","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108565_bb0105","first-page":"106","article-title":"CDK inhibitors from past to present: a new wave of cancer therapy, seminars in Cancer biology","author":"Mughal","year":"2023","journal-title":"Elsevier"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108565_bb0110","article-title":"Roscovitine in cancer and other diseases","volume":"3","author":"Cicenas","year":"2015","journal-title":"Annals of translational medicine"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108565_bb0115","first-page":"443","article-title":"Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma","volume":"125","author":"Kumar","year":"2015","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108565_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234103","article-title":"Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer","volume":"15","author":"Frame","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108565_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113781","article-title":"Pyrazolopyrimidines as anticancer agents: a review on structural and target-based approaches","volume":"225","author":"Asati","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108565_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2017.05.010","article-title":"Antibacterial activity and mechanism of action of the benzazole acrylonitrile-based compounds: in vitro, spectroscopic, and docking studies","volume":"136","author":"AlNeyadi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/10426509908044970","article-title":"Revised synthesis of some new derivatives of biological interest 2-heterocyclic benzothiazolyl derivatives of biological interest","volume":"155","author":"Fadda","year":"1999","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ardp.200900082","article-title":"Facile synthesis and in-vitro antitumor activity of some pyrazolo [3, 4-b] pyridines and pyrazolo [1, 5-a] pyrimidines linked to a thiazolo [3, 2-a] benzimidazole moiety","volume":"343","author":"Abdel-Aziz","year":"2010","journal-title":"Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108565_bb0145","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ejmech.2008.02.002","article-title":"Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1, 3-thiazolino [5, 4-b] quinoxaline derivatives and evaluation of their antiamoebic activity","volume":"44","author":"Budakoti","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"S1","key":"10.1016\/j.bioorg.2025.108565_bb0150","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1002\/jhet.1824","article-title":"Synthesis of 2, 5, 7-Triaryl-4, 7 (6, 7)-dihydropyrazolo [1, 5-a] pyrimidine-3-carbonitriles by reaction of 5 (3)-Amino-3 (5)-aryl-1H-pyrazole-4-carbonitriles with Chalcones","volume":"51","author":"Kolosov","year":"2014","journal-title":"J. Heterocyclic Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108565_bb0155","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1021\/jo00115a023","article-title":"Synthesis of 3-substituted pentane-2, 4-diones: valuable intermediates for liquid crystals","volume":"60","author":"Cativiela","year":"1995","journal-title":"J. Organomet. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0160","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1038\/s41598-022-15050-8","article-title":"Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity","volume":"12","author":"Eldehna","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108565_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105995","article-title":"Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: in vitro, in vivo, molecular docking, molecular dynamics, and SAR studies","volume":"127","author":"Hammouda","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108565_bb0170","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1021\/acs.jmedchem.3c00721","article-title":"1, 5-diaryl-1, 2, 4-triazole ureas as new SLC-0111 analogues endowed with dual carbonic anhydrase and VEGFR-2 inhibitory activities","volume":"66","author":"Elsawi","year":"2023","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108565_bb0175","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/ph17020216","article-title":"Design, synthesis and biological assessment of N\u2032-(2-Oxoindolin-3-ylidene)-6-methylimidazo [2, 1-b] thiazole-5-carbohydrazides as potential anti-proliferative agents toward MCF-7 breast Cancer","volume":"17","author":"Alshaye","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108565_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107644","article-title":"Novel imidazo [2, 1-b] thiazoles and imidazo [1, 2-a] pyridines tethered with indolinone motif as VEGFR-2 inhibitors and apoptotic inducers: design, synthesis and biological evaluations","volume":"151","author":"Elkotamy","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108565_bb0185","article-title":"Uchil, analysis of cell viability by the MTT assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb Protoc"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108565_bb0190","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.febslet.2006.03.041","article-title":"DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation","volume":"580","author":"Alimirah","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2025.108565_bb0195","article-title":"Design, synthesis, and molecular dynamics-driven evaluation of quinoline-sulfonamide derivatives as potent and selective EGFR inhibitors with promising anti-cancer efficacy and safety profiles","volume":"108247","author":"Elkotamy","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108565_bb0200","first-page":"67","article-title":"DNA measurement and cell cycle analysis by flow cytometry","volume":"3","author":"Nunez","year":"2001","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108565_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107766","article-title":"Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction","volume":"153","author":"Elgohary","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108565_bb0210","article-title":"Development of pyrazolo [1, 5-a] pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity","volume":"140462","author":"Elkotamy","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108565_bb0215","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.7314\/APJCP.2012.13.10.4873","article-title":"Apoptosis in cancer-an update","volume":"13","author":"Sankari","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108565_bb0220","first-page":"197","article-title":"Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity, cytometry","volume":"37","author":"Aubry","year":"1999","journal-title":"The Journal of the International Society for Analytical Cytology"},{"key":"10.1016\/j.bioorg.2025.108565_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.991659","article-title":"Histamine activates an intracellular Ca2+ signal in normal human lung fibroblast WI-38 cells","volume":"10","author":"Berra-Romani","year":"2022","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/j.bioorg.2025.108565_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2025.2475233","article-title":"Design, synthesis and biological evaluation of pyrazolo [3, 4-b] pyridine derivatives as dual CDK2\/PIM1 inhibitors with potent anti-cancer activity and selectivity","author":"Elkotamy","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108565_bb0235","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/molecules25092031","article-title":"Synthesis, biological evaluation and in silico studies of certain oxindole\u2013indole conjugates as anticancer CDK inhibitors","volume":"25","author":"Al-Warhi","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108565_bb0240","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drudis.2019.12.001","article-title":"Targeting CDK2 in cancer: challenges and opportunities for therapy","volume":"25","author":"Tadesse","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108565_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117158","article-title":"Design, synthesis, and evaluation of novel benzofuran and pyrazole-based derivatives as dual AChE\/BuChE inhibitors with antioxidant properties for Alzheimer\u2019s disease management","volume":"283","author":"Elkotamy","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108565_bb0250","article-title":"Targeting cyclin-dependent kinase 2 CDK2: insights from molecular docking and dynamics simulation-a systematic computational approach to discover novel cancer therapeutics","volume":"108134","author":"Chagaleti","year":"2024","journal-title":"Comput. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0255","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/s41467-023-38732-x","article-title":"Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding","volume":"14","author":"Faber","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108565_bb0260","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108565_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.137554","article-title":"Spiro-fused indoline-quinazoline hybrids as smart bombs against TNF-\u03b1-mediated inflammation","volume":"283","author":"Elkotamy","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108565_bb0270","article-title":"Sulfonamide-Pyrazole derivatives as next-generation Cyclooxygenase-2 enzyme inhibitors: from molecular design to in vivo efficacy","volume":"139170","author":"Elgohary","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108565_bb0275","first-page":"gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T13:14:27Z","timestamp":1753449267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":55,"alternative-id":["S0045206825004456"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108565","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Benzothiazole-grafted Pyrazolo[1,5-a]pyrimidines as new CDK2 inhibitors and anti-prostate cancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108565"}}